{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:52:09Z","timestamp":1789761129002,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ctro.2022.10.001","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T11:26:29Z","timestamp":1665228389000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Radiation therapy for primary orbital and ocular adnexal lymphoma"],"prefix":"10.1016","volume":"38","author":[{"given":"Maria Valeria","family":"Pereira-Da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiberto","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normand","family":"Laperriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Krema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2022.10.001_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","article-title":"Orbital lymphoma","volume":"64","author":"Olsen","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ctro.2022.10.001_b0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2018.11.002","article-title":"Orbital Lymphoma-An International Multicenter Retrospective Study","volume":"199","author":"Olsen","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ctro.2022.10.001_b0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000499845","article-title":"Understanding and Classification of Ocular Lymphomas","volume":"5","author":"White","year":"2019","journal-title":"Ocul Oncol Pathol"},{"issue":"10","key":"10.1016\/j.ctro.2022.10.001_b0020","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.ctro.2022.10.001_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-3768.2008.01478.x","article-title":"Ophthalmic lymphoma: epidemiology and pathogenesis","volume":"87 Thesis 1","author":"Sj\u00f6","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ctro.2022.10.001_b0030","first-page":"271","article-title":"Characteristics of orbital lymphoma: a clinicopathological study of 26 cases","volume":"38","author":"Briscoe","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"9","key":"10.1016\/j.ctro.2022.10.001_b0035","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1503\/cmaj.191292","article-title":"Projected estimates of cancer in Canada in 2020","volume":"192","author":"Brenner","year":"2020","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.ctro.2022.10.001_b0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2017.05.037","article-title":"Treatments for Ocular Adnexal Lymphoma: A Report by the American Academy of Ophthalmology","volume":"125","author":"Yen","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ctro.2022.10.001_b0050","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0161-6420(98)98024-1","article-title":"Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases","volume":"105","author":"Coupland","year":"1998","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: A study of 353 cases","volume":"31","author":"Ferry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctro.2022.10.001_b0065","doi-asserted-by":"crossref","unstructured":"Goda, J.S., et al., Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys, 2011. 81(4): p. e659-66.","DOI":"10.1016\/j.ijrobp.2011.03.050"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10238-017-0474-1","article-title":"Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue","volume":"18","author":"Kalogeropoulos","year":"2018","journal-title":"Clin Exp Med"},{"issue":"6","key":"10.1016\/j.ctro.2022.10.001_b0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hed.24717","article-title":"Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma","volume":"39","author":"Pinnix","year":"2017","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0161-6420(01)00932-0","article-title":"Orbital tumors in the older adult population","volume":"109","author":"Demirci","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ctro.2022.10.001_b0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.ctro.2022.10.001_b0090","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ctro.2022.10.001_b0095","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/annonc\/mdl124","article-title":"Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial","volume":"17","author":"Ferreri","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2022.10.001_b0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00277-014-2240-8","article-title":"Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma","volume":"94","author":"Han","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctro.2022.10.001_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/895105","article-title":"Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa","volume":"2015","author":"Annibali","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.ctro.2022.10.001_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/eye.2012.241","article-title":"Radiotherapy for ocular tumours","volume":"27","author":"Stannard","year":"2013","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ctro.2022.10.001_b0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2004.03.039","article-title":"Orbital lymphoma: is it necessary to treat the entire orbit?","volume":"60","author":"Pfeffer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2022.10.001_b0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.prro.2015.11.013","article-title":"Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma","volume":"6","author":"Binkley","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2022.10.001_b0130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy x 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:10:11Z","timestamp":1762503011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630822000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"alternative-id":["S2405630822000854"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2022.10.001","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation therapy for primary orbital and ocular adnexal lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}